Neogen Chemicals Rectifies Financial Ratios in Q2 FY2026 Results

Neogen Chemicals Limited , a prominent player in the Indian chemical industry, has issued a corrigendum to address typographical errors in its unaudited financial results for the quarter and half-year ended September 30, 2025. The company has revised several key financial ratios in both its standalone and consolidated results, emphasizing that these corrections do not materially impact the financial statements.

Standalone Results Corrections

The company has made significant adjustments to its standalone financial ratios:

Ratio	Previous Value	Corrected Value
Trailing Twelve Months Debt Service Coverage Ratio (DSCR)	2.11	2.38
Trailing Twelve Months Interest Service Coverage Ratio (ISCR)	3.59	2.51

Consolidated Results Revisions

For the consolidated results, Neogen Chemicals has made the following corrections:

Ratio	Period	Previous Value	Corrected Value
Quarterly DSCR	Q2 FY2026	0.75	0.97
Half-Yearly DSCR	H1 FY2026	0.99	1.44
Trailing Twelve Months DSCR	-	0.77	1.99

Impact and Company Statement

Neogen Chemicals has clarified that these corrections are not material errors and do not impact the financial statements in any manner. The company promptly executed the necessary corrections upon noticing the inadvertent typographical errors in Note No. 1 of its financial results.

Transparency Measures

In line with regulatory requirements, Neogen Chemicals has:

Submitted the revised information to both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE).
Updated the corrected financial information on the company's official website.
Hosted an Earnings Conference Call for analysts and investors on November 10, 2025, with the audio recording available on the company's website.

These actions demonstrate Neogen Chemicals' commitment to transparency and accurate financial reporting, ensuring that investors and stakeholders have access to the most up-to-date and correct financial information.

Investors and analysts are advised to refer to the corrected ratios for a more accurate assessment of Neogen Chemicals' financial performance for the quarter and half-year ended September 30, 2025.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-1.17%	-7.84%	-20.92%	-30.72%	-44.17%	+85.48%

Neogen Chemicals Limited , a prominent player in the specialty chemicals sector, has announced its financial results for the quarter ended September 30, 2025, showcasing a mixed performance with revenue growth and regulatory challenges.

Revenue and Profit Performance

The company reported a revenue from operations of ₹206.68 crore for Q2 FY2026, marking a significant increase from ₹186.54 crore in the corresponding quarter of the previous year. This 10.8% year-on-year growth demonstrates Neogen Chemicals' resilience in a competitive market landscape.

Neogen Chemicals' profit after tax for the quarter stood at ₹9.31 crore, reflecting the company's ability to maintain profitability amidst various operational challenges.

Financial Highlights

Particulars (in ₹ crore)	Q2 FY2026	Q2 FY2025	YoY Change
Revenue from Operations	206.68	186.54	+10.8%
Profit After Tax	9.31	-	-

Regulatory Compliance and Fines

The company disclosed receipt of fine notices from both BSE and NSE, totaling ₹1,69,920. These fines were imposed for non-compliance with Regulation 17(1A) of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations. The regulation pertains to the requirement of passing a special resolution for the continuation of a non-executive director beyond the age of 75 years.

Neogen Chemicals has stated that it has applied for a waiver of these fines and is currently awaiting a response from the stock exchanges.

Insurance Claim Update

During the half-year period, Neogen Chemicals received ₹80.92 crore from insurance claims related to a fire incident at its Dahej plant in March 2025. This substantial inflow is expected to aid in the company's recovery and operational stabilization following the incident.

Debt Issuance

In a move to strengthen its financial position, Neogen Chemicals issued non-convertible debentures (NCDs) worth ₹200 crore in August 2025. This debt issuance may provide the company with additional capital for its growth initiatives and operational needs.

Outlook

While Neogen Chemicals has demonstrated revenue growth, the regulatory fine and the ongoing recovery from the March 2025 fire incident present challenges that the company will need to navigate carefully. The successful resolution of the compliance issue and the effective utilization of the insurance claim proceeds will be crucial for the company's performance in the coming quarters.

Investors and market observers will likely keep a close watch on how Neogen Chemicals balances its growth initiatives with regulatory compliance and operational recovery in the near future.